What is the FDA recommended regimen of streptokinase for thrombolytic therapy of pulmonary embolism (PE)?

Updated: Dec 31, 2017
  • Author: Wanda L Rivera-Bou, MD, FAAEM, FACEP; Chief Editor: Erik D Schraga, MD  more...
  • Print
Answer

Answer

The FDA-approved streptokinase regimen for PE consists of 250,000 U as a loading dose over 30 minutes, followed by 100,000 U/hr over 12-24 hours.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!